BRPI0509494A - lactonas antiinflamatórias - Google Patents

lactonas antiinflamatórias

Info

Publication number
BRPI0509494A
BRPI0509494A BRPI0509494-1A BRPI0509494A BRPI0509494A BR PI0509494 A BRPI0509494 A BR PI0509494A BR PI0509494 A BRPI0509494 A BR PI0509494A BR PI0509494 A BRPI0509494 A BR PI0509494A
Authority
BR
Brazil
Prior art keywords
lactones
inflammatory
lactons
inflammation
relates
Prior art date
Application number
BRPI0509494-1A
Other languages
English (en)
Inventor
Josef Gottfried Meingassner
Klaus Thirring
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0407466A external-priority patent/GB0407466D0/en
Priority claimed from GB0407467A external-priority patent/GB0407467D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0509494A publication Critical patent/BRPI0509494A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LACTONAS ANTIINFLAMATóRIAS. A presente invenção refere-se a lactonas, que são farmaceuticamente ativas em doenças associadas com inflamação.
BRPI0509494-1A 2004-04-01 2005-03-31 lactonas antiinflamatórias BRPI0509494A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0407466A GB0407466D0 (en) 2004-04-01 2004-04-01 Organic compounds
GB0407467A GB0407467D0 (en) 2004-04-01 2004-04-01 Organic compounds
PCT/EP2005/003384 WO2005097771A1 (en) 2004-04-01 2005-03-31 Antiinflammatory lactones

Publications (1)

Publication Number Publication Date
BRPI0509494A true BRPI0509494A (pt) 2007-09-11

Family

ID=34966979

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509494-1A BRPI0509494A (pt) 2004-04-01 2005-03-31 lactonas antiinflamatórias

Country Status (14)

Country Link
US (1) US7414074B2 (pt)
EP (1) EP1735295B1 (pt)
JP (1) JP2007530630A (pt)
KR (1) KR20070015529A (pt)
AT (1) ATE394385T1 (pt)
AU (1) AU2005231939B2 (pt)
BR (1) BRPI0509494A (pt)
CA (1) CA2558244A1 (pt)
DE (1) DE602005006547D1 (pt)
ES (1) ES2303245T3 (pt)
PL (1) PL1735295T3 (pt)
PT (1) PT1735295E (pt)
RU (1) RU2006138429A (pt)
WO (1) WO2005097771A1 (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666482A5 (de) * 1984-02-08 1988-07-29 Sandoz Ag Metabolit, dessen herstellung und verwendung.
JP2002047281A (ja) * 2000-07-28 2002-02-12 Mitsubishi-Tokyo Pharmaceuticals Inc テロメレース阻害剤

Also Published As

Publication number Publication date
AU2005231939B2 (en) 2008-05-22
ES2303245T3 (es) 2008-08-01
KR20070015529A (ko) 2007-02-05
DE602005006547D1 (de) 2008-06-19
CA2558244A1 (en) 2005-10-20
US20070219143A1 (en) 2007-09-20
US7414074B2 (en) 2008-08-19
ATE394385T1 (de) 2008-05-15
WO2005097771A1 (en) 2005-10-20
JP2007530630A (ja) 2007-11-01
RU2006138429A (ru) 2008-05-10
EP1735295A1 (en) 2006-12-27
AU2005231939A1 (en) 2005-10-20
EP1735295B1 (en) 2008-05-07
PT1735295E (pt) 2008-06-23
PL1735295T3 (pl) 2008-10-31

Similar Documents

Publication Publication Date Title
MX2007015424A (es) Formulaciones ungueales topicas.
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
ECSP11011054A (es) Péptidos antivirales terapéuticos
UA93903C2 (ru) Производные тетрагидроизохинолина для повышения функции памяти
HUE052378T2 (hu) Lokális topikális adagolású, indoxacarb tartalmú formulációk
NO20091064L (no) Antistoffer mot IL-17A
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
MX2010005385A (es) Medicamentos topicos para la terapia antimicotica.
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
BRPI0508403A (pt) produtos de pelìcula tendo propriedades de desintegração controlada
MX339255B (es) Una para usarse en el rejuvenecimiento de la piel que comprende, eosina y , un oxidante y un factor cicatrizante.
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
EA201170703A1 (ru) Производные адамантилбензамида
CY1110097T1 (el) Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
WO2008142569A3 (en) Topical compositions containing magaldrate
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
ATE509958T1 (de) Gegen cathepsin s gerichtete therapie
EA200601759A1 (ru) Композиции рамиприла
TW200640724A (en) Display for a vehicle
RU2007122391A (ru) S-миртазапин для лечения приливов
CR11735A (es) Asociacion de la dronedarona con al menos un diuretico, su aplicacion en terapeutica
DK1880727T3 (da) Topisk vaginal farmaceutiske sammensætninger

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.